来自辛吉贝拉属植物的植物分子抑制日本脑炎病毒RNA依赖RNA聚合酶:一个分子动力学研究
Aftab Alam1, Asma Anjum2, Ehssan H Moglad3,4
1Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Journal of biomolecular structure & dynamics
|March 15, 2024
概括
来自紫杉科 (Zingeberaceae) 家族的植物化学化合物显示出作为日本脑炎病毒 (JEV) 抗剂的希望. 这项研究确定了向JEV RdRp蛋白的顶级化合物,表明了新的抗病毒疗法的潜力.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 日本脑炎病毒 (JEV) 是东南亚和西太平洋地区的一种重要的黄病毒威胁,由Culex蚊子传播.
- 鸟是自然的储存库,而猪在流行病期间放大病毒,对人类群体构成风险.
- 目前的JEV疫苗存在局限性,包括对所有隔离物不完全有效以及潜在的神经副作用.
研究的目的:
- 选来自Zingeberaceae家族的植物化学化合物对抗JEV的抗病毒活性.
- 为了确定抑制JEVRNA依赖RNA聚合酶 (RdRp) 蛋白的特定化合物.
- 评估潜在的JEV抑制剂的结合亲和力和动态稳定性.
主要方法:
- 使用分子对接,对501种植物化学化合物的JEV RdRp蛋白进行in silico选.
- 结合相互作用的分析,包括键和疏水性相互作用.
- 分子动力学模拟和自由能量景观分析,以评估复杂的稳定性.
主要成果:
- 五种辛格贝拉ceae植物化学化合物 (IMPHY014466,IMPHY004928,IMPHY007097,IMPHY014179,IMPHY005010) 显示出对JEV RdRp具有显著的结合亲和力 (对接分数> -8.0 Kcal/mol).
- 详细的分子相互作用和结合方式被阐明.
- 分子动力学模拟证实了对接复合体的稳定性.
结论:
- 来自辛格贝拉家族的植物化学物质具有强大的潜力作为JEV对手.
- 这些化合物需要进一步的实验验证,以开发针对日本脑炎的新型抗病毒策略.
- 这些已识别的化合物代表了未来针对JEV的药物发现工作的有希望的线索.
相关概念视频
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Types of RNA
63.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.7K
Ribozymes
12.3K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.3K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


